ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Cohance Lifesciences Limited conducted its 8th Annual General Meeting on 17 September 2026. All resolutions proposed in the notice were passed by the requisite majority.
Cohance Lifesciences Limited will conduct its 8th Annual General Meeting on 17 September 2026 via video conference. The agenda includes adopting financial statements and director reappointment.
Cohance Lifesciences shareholders approved all five resolutions via postal ballot. The resolutions include appointment of Chairman and CEO, remuneration, and ESOP plans.
Cohance Lifesciences issued a postal ballot notice for appointing Mr. Umang Vohra as Chairman and CEO. Shareholders will also vote on a new ESOP 2026 plan.